Inovio Pharmaceuticals
INO
#8896
Rank
$0.14 B
Marketcap
$2.07
Share price
2.48%
Change (1 day)
-50.00%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $77.1 Million USD

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are $77.1 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$44.69 M-16.62%
2023-12-31$53.6 M-57.52%
2022-12-31$0.12 B31.06%
2021-12-31$96.27 M22.43%
2020-12-31$78.63 M-43.25%
2019-12-31$0.13 B214.3%
2018-12-31$44.08 M-1.5%
2017-12-31$44.75 M-11.08%
2016-12-31$50.32 M32.77%
2015-12-31$37.9 M87.22%
2014-12-31$20.24 M-42.78%
2013-12-31$35.38 M244.16%
2012-12-31$10.28 M-22.38%
2011-12-31$13.24 M47.72%
2010-12-31$8.96 M-53.89%
2009-12-31$19.44 M-2.2%
2008-12-31$19.88 M127.46%
2007-12-31$8.74 M-29.78%
2006-12-31$12.44 M125.99%
2005-12-31$5.5 M1.97%
2004-12-31$5.4 M357.27%
2003-12-31$1.18 M-30.26%
2002-12-31$1.69 M1.39%
2001-12-31$1.67 M
2001-03-31$1.59 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$115.63 B 149,869.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$113.53 B 147,151.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
$0.86 B 1,016.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$62.53 B 81,005.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
$77.63 B 100,591.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$61.28 B 79,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
$37.07 B 47,986.00%๐Ÿ‡บ๐Ÿ‡ธ USA